| Date Checked | 2026-02-19 22:17:06 |
|---|---|
| Graham Number | (PB)44.77 vs (PE)46.27 |
| Over / Under Value Percentage | 98.97% vs 95.61% |
| Dividend Yield | 1.64% |
| Dividend Date | 2025-09-08 |
| Symbol | AZN |
| AssetType | Common Stock |
| Name | AstraZeneca PLC ADR |
| Description | AstraZeneca PLC is a prominent global biopharmaceutical company headquartered in Cambridge, UK, specializing in the discovery, development, and commercialization of innovative prescription medicines across key therapeutic areas, including oncology, cardiovascular, renal, respiratory, and neuroscience. With a robust pipeline and a strong commitment to addressing unmet medical needs, AstraZeneca leverages advanced scientific research and strategic collaborations to propel its growth and improve patient outcomes worldwide. The company is also dedicated to sustainability initiatives, positioning itself to navigate and benefit from the evolving dynamics of the healthcare sector. |
| CIK | 901832 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address | 1 FRANCIS CRICK AVENUE, CAMBRIDGE, UNITED KINGDOM, CB2 0AA |
| OfficialSite | https://www.astrazeneca.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 295049986000 |
| EBITDA | 20416000000 |
| PERatio | 31.61 |
| PEGRatio | 1.093 |
| BookValue | 29.59 |
| DividendPerShare | 3.13 |
| EPS | 3.01 |
| RevenuePerShareTTM | 3.113 |
| ProfitMargin | 0.162 |
| OperatingMarginTTM | 0.241 |
| ReturnOnAssetsTTM | 0.0906 |
| ReturnOnEquityTTM | 0.217 |
| RevenueTTM | 58127000000 |
| GrossProfitTTM | 48395002000 |
| DilutedEPSTTM | 3.01 |
| QuarterlyEarningsGrowthYOY | 0.78 |
| QuarterlyRevenueGrowthYOY | 0.12 |
| AnalystTargetPrice | 98.96 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 8 |
| AnalystRatingHold | 1 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 31.61 |
| ForwardPE | 18.48 |
| PriceToSalesRatioTTM | 5.08 |
| PriceToBookRatio | 6.43 |
| EVToRevenue | 5.47 |
| EVToEBITDA | 17.72 |
| Beta | 0.193 |
| 52WeekHigh | 96.51 |
| 52WeekLow | 60.83 |
| 50DayMovingAverage | 89.07 |
| 200DayMovingAverage | 77.96 |
| SharesOutstanding | 3100567000 |
| SharesFloat | 1543493000 |
| PercentInsiders | 0.002 |
| PercentInstitutions | 16.753 |
| ExDividendDate | 2025-08-08 |
| naga | 0 |
| etoro | 1 |
| dateChecked | 2026-02-19 22:17:06 |
| fresh | 1 |